Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human lecithin cholesterol acyltransferase

EU orphan designation number: EU/3/12/1051   
Active ingredient: Recombinant human lecithin cholesterol acyltransferase
Indication: Treatment of lecithin cholesterol acyltransferase deficiency
Sponsor: AstraZeneca UK Limited
Charter Way, Macclesfield, Cheshire East SK10 2NA, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2012 Orphan designation EMA/OD/091/12 (2012)7228 of 10/10/2012
02/03/2016 Transfer of orphan designation EMA/OD/091/12/T/01 (2016)1376 of 29/02/2016